Psilocybin is the main psychoactive ingredient in hallucinogenic mushrooms, also called "magic mushrooms" or "shrooms." There are over 100 species of mushrooms that contain psilocybin.
Although people have been consuming magic mushrooms for thousands of years, the compound wasn't isolated until 1957 and it was produced synthetically a year later. Since 1970, psilocybin and psilocin (a closely related compound) have been listed by the U.S. Drug Enforcement Association (DEA) as Schedule I substances the federal government's most restrictive category.
Despite these restrictions, recent clinical trials have found psilocybin to be a promising therapy for treatment-resistant anxiety and depression. Because of this, the U.S. Food and Drug Administration (FDA) has designated psilocybin as a "breakthrough therapy" an action meant to accelerate the drug development and review process.
There are over 100 species of psilocybin-containing mushrooms with varying potencies, said Matthew Johnson, an associate professor of psychiatry and behavioral sciences at Johns Hopkins School of Medicine in Baltimore who studies psychedelic drugs such as psilocybin.
Psilocybin mushrooms have long, slender stems topped by caps with dark brown edges, according to the DEA. In the U.S., magic mushrooms are found in the Southeast and Pacific Northwest often growing in pastures on cow dung, Johnson told Live Science. They also grow in Mexico, Central and South America. The most potent species in the world is considered Psilocybe azurescens, which is found mainly in the U.S. Pacific Northwest.
In the early 1950s, an American banker and mushroom enthusiast named R. Gordon Wasson came across an indigenous tribe using psychoactive mushrooms when he was on vacation in Mexico, according to Drug Policy Alliance. Wasson sent samples of the mushrooms to Albert Hoffmann, a Swiss chemist known for discovering LSD. Hoffmann isolated psilocybin from the mushroom Psilocybe mexicana in 1957, and he developed a way to produce a synthetic version of the psychedelic compound a year later.
Since 1970, psilocybin and psilocin have been listed by the DEA as Schedule I substances, the federal government's most restrictive category. Drugs in this category are believed to have a "high potential for abuse" as well as "no accepted medical use," according to the DEA.
Psilocybin along with other drugs, such as lysergic acid diethylamide (LSD) and mescaline, are considered "classic psychedelics" because they can induce changes in mood, thought and perception by mimicking neurotransmitters in your brain.
Once it enters the body, psilocybin is broken down into psilocin, a substance that acts like the neurotransmitter serotonin, which regulates mood. Psilocybin is known to activate a specific type of serotonin receptor in the brain that triggers its psychedelic effects, Johnson said.
Its hallucinatory effects can cause a person to see images, hear sounds and feel sensations that seem real but aren't, according to Partnership for Drug-Free Kids. Someone on psilocybin may experience synesthesia, or the mixture of two senses, such as feeling like they can smell colors.
Related: 'Trippy' bacteria engineered to brew 'magic mushroom' hallucinogen
Besides sensory enhancement and visual hallucinations, participants in psilocybin-assisted therapy sessions have described the drug's effects as a life-changing experience where they gain deep insight that shifts the way they think about themselves.
A mystical type of experience has also been linked with the use of psilocybin, Johnson said. People have described feeling at one with humanity, feeling a sense of unity, and feeling a sense of self dissolve after consuming the psychedelic compound, he explained.
Studies have shown that after taking psilocybin, there is a sharp increase in communication between areas of the brain that normally don't talk to each other, which may partly explain the new insights people experience. There's also a quieting of deeply entrenched thought patterns that contribute to addictions, anxiety and depression, Johnson said.
People have been ingesting psilocybin-containing mushrooms for thousands of years as part of religious ceremonies or for healing purposes.
Magic mushrooms can be made into a tea, eaten raw or dried, ground into a powder and put in capsules, or coated in chocolate, to mask their bitter flavor and disguise them as candy, Johnson said. The hallucinogenic effects may begin within 20 to 40 minutes of use and last about 3 to 6 hours, according to the U.S. Department of Justice.
Studies on the possible medical benefits of psilocybin and other psychedelics began in the 1950s and '60s, immediately after Hoffmann created a way to produce the chemical synthetically.
Although findings showed promise for treating anxiety, depression and addiction, research in the U.S. came to a halt in 1970, when President Richard Nixon signed the Controlled Substances Act. This law was viewed as a political response to a growing fear of psychedelic drug use in young people and the spread of the counterculture movement.
Three decades later, Roland Griffiths, a psychopharmacologist at Johns Hopkins, won FDA approval to study psilocybin, ushering in a new era of psychedelics research with more rigorous scientific standards than earlier studies.
When used in current research sessions, participants take a pill containing a high dose of synthetic psilocybin with professionals monitoring them and providing psychological support, Johnson said. They typically receive counseling before and after the psychedelic experience.
The FDA has granted some scientists permission to use psilocybin in research but the recreational use of psilocybin is illegal in the U.S. However, its illicit use has been decriminalized in two cities (Denver and Oakland, California) and other cities are working on similar measures, Johnson said.
Psilocybin has shown promise for treating a variety of difficult-to-treat health conditions.
For example, the results are extremely positive for the use of psilocybin in the treatment of smoking cessation and depression, Johnson said. Recent clinical trials have reported that just one to three doses of psilocybin given in conjunction with cognitive behavioral therapy have helped patients quit their smoking habit, he said. Afterward, people feel more confident in their ability to change behavior and manage their addictions.
Results are also promising for the use of psilocybin in reducing cancer-related anxiety and treatment-resistant depression two areas where there is a huge need for better treatment options, Johnson said.
Psilocybin along with supportive therapy appears to help people come to grips with problems and learn from these experiences, he said. The treatment may induce insights and novel perspectives that promote mental flexibility and may cause lasting behavior changes six months to a year later.
Small studies of psilocybin have also suggested benefits as a treatment for alcohol addiction and obsessive-compulsive disorder.
The most common negative side effect of psilocybin is the potential for a "bad trip," Johnson said. High doses of psilocybin can cause overwhelming feelings of anxiety, fear and confusion that can lead to dangerous behavior if not used under medical supervision.
Psychedelics are very intoxicating substances, and their side effects can be challenging to manage even in the relatively safe framework of a research setting, Johnson said. Researchers reduce these risks by prohibiting people with a history of psychosis from participating in psilocybin studies. Psilocybin can also moderately increase blood pressure, which is why people with heart problems are excluded from studies, he added. Other possible side effects of psilocybin use include nausea, vomiting, headaches and stomach cramps.
For recreational users, misidentification of mushroom species is one of the biggest concerns. Some poisonous varieties of mushrooms in the wild bear a strong resemblance to psilocybin species, according to ProjectKnow. Inexperienced mushroom hunters might not recognize the difference, and could accidentally ingest a poisonous mushroom, which could lead to liver failure or death.
Additional resources:
This article is for informational purposes only, and is not meant to provide medical advice.
Here is the original post:
Psilocybin: The magic ingredient in psychedelic shrooms - Livescience.com
- 8 Mystical Herbs and Legal Psychedelics For Lucid Dreaming - December 8th, 2016 [December 8th, 2016]
- Psychedelics: LSD, Mushrooms, Salvia | Facts | Drug Policy ... - December 10th, 2016 [December 10th, 2016]
- FS Book Company - Marijuana Books - December 12th, 2016 [December 12th, 2016]
- Psychedelic - PsychonautWiki - December 27th, 2016 [December 27th, 2016]
- From Alzheimer's To Psychedelics, 2016 Was A Good Year For ... - January 3rd, 2017 [January 3rd, 2017]
- LSD - Psychedelic Effects - The Good Drugs Guide - January 5th, 2017 [January 5th, 2017]
- THC - Psychedelics - January 29th, 2017 [January 29th, 2017]
- Psychedelics | Pharmacological Reviews - January 30th, 2017 [January 30th, 2017]
- Dorian Yates reveals all on steroids, body dysmorphia, psychedelics, cannabis and yoga - Express.co.uk - February 7th, 2017 [February 7th, 2017]
- Psychedelic drug therapy including magic mushrooms, LSD and ... - CBS News - February 7th, 2017 [February 7th, 2017]
- Psychedelics Being Tested For Use In Treating Various Conditions - CBS Local - February 8th, 2017 [February 8th, 2017]
- The psychedelic renaissance - Boulder Weekly - February 9th, 2017 [February 9th, 2017]
- Buy psychedelics online : Chinglabs.com - February 12th, 2017 [February 12th, 2017]
- Psychedelic drugs like magic mushrooms and LSD have key ... - Yahoo Finance - February 13th, 2017 [February 13th, 2017]
- Psychedelics a Viable Therapeutic Option for Depression - Psychiatry Advisor - February 14th, 2017 [February 14th, 2017]
- Is Silicon Valley Onto Something With Its LSD Microdosing? - Newsweek - February 15th, 2017 [February 15th, 2017]
- News Releases - Noozhawk - February 16th, 2017 [February 16th, 2017]
- A Revolution in the Science of Psychedelics is Happening in Boulder - 303 Magazine - February 16th, 2017 [February 16th, 2017]
- When Reality Is More Intense Than Psychedelics: Strand Of Oaks ... - NPR - February 17th, 2017 [February 17th, 2017]
- Psychedelics Help Reduce Opioid Addiction, According to New Study - AlterNet - February 22nd, 2017 [February 22nd, 2017]
- Psychedelics May Help Reduce Opioid Addiction, According To ... - Huffington Post - February 23rd, 2017 [February 23rd, 2017]
- Psychedelics Help Reduce Opioid Addiction, According to New Study - eNews Park Forest - February 24th, 2017 [February 24th, 2017]
- Psychedelics Could Play A Role In Tackling The Opioid Epidemic - Huffington Post - February 24th, 2017 [February 24th, 2017]
- Meet The People's Champion of Psychedelic Drugs - Narratively - February 27th, 2017 [February 27th, 2017]
- How psychedelics like psilocybin and LSD actually change the way ... - Yahoo Finance - February 27th, 2017 [February 27th, 2017]
- First U. student group on studying psychedelics holds open house - The Daily Princetonian - February 27th, 2017 [February 27th, 2017]
- How psychedelics like psilocybin and LSD actually change the way people see the world - Businessinsider India - February 28th, 2017 [February 28th, 2017]
- Psychedelics Help Reduce Opioid Addiction, According to New ... - February 28th, 2017 [February 28th, 2017]
- WATCH: A Public Policy Expert Explains How to Safely Deregulate LSD and Other Psychedelics - AlterNet - March 7th, 2017 [March 7th, 2017]
- Quotes About Psychedelics (48 quotes) - March 7th, 2017 [March 7th, 2017]
- Inside the Psychedelic Underground - RollingStone.com - March 9th, 2017 [March 9th, 2017]
- What Psychedelics Really Do to Your Brain - Rolling Stone - RollingStone.com - March 10th, 2017 [March 10th, 2017]
- Hallucinogens Help, According to a Mom's Memoir and Son's Documentary - Bedford + Bowery - April 8th, 2017 [April 8th, 2017]
- Meditation and the psychedelic drug ayahuasca seem to change the brain in surprisingly similar ways - Businessinsider India - April 8th, 2017 [April 8th, 2017]
- Tripping out: the highs and lows of psychedelic therapy - Marie Claire UK - April 8th, 2017 [April 8th, 2017]
- Stop Policing Psychedelic Science - Motherboard - June 6th, 2017 [June 6th, 2017]
- America's Trippiest Chemist: Making Psychedelics 'Was Fun' - Motherboard - June 6th, 2017 [June 6th, 2017]
- The Three Types of Hallucinogens: Psychedelics ... - June 7th, 2017 [June 7th, 2017]
- Cary Grant was one of the first to benefit from LSD therapy - Quartz - June 11th, 2017 [June 11th, 2017]
- What it's like to take psychedelics in small doses at breakfast - New Scientist - June 14th, 2017 [June 14th, 2017]
- 'Changing Our Minds' explores psychedelic drugs and spiritual healing - Religion News Service - June 14th, 2017 [June 14th, 2017]
- Q&A With Psychedelic Stand-Up and LaughFest Headliner Shane Mauss - Flagpole Magazine - June 20th, 2017 [June 20th, 2017]
- Q&A: LaughFest comedian talks science and psychedelics - Red and Black - June 20th, 2017 [June 20th, 2017]
- 'Changing Our Minds' explores psychedelic drugs and spiritual healing - The Daily Tribune - June 21st, 2017 [June 21st, 2017]
- Shane Mauss brings Good Trip Comedy Tour to town - Chattanooga Times Free Press - June 22nd, 2017 [June 22nd, 2017]
- 'Changing Our Minds' explores psychedelic drugs and spiritual healing - The Oakland Press - June 22nd, 2017 [June 22nd, 2017]
- Director Ana Lily Amirpour on Cannibalism, Psychedelics, and 'Horrifying' Racism Allegations - Jezebel - June 23rd, 2017 [June 23rd, 2017]
- Majority of Americans ready to embrace psychedelic therapy - YouGov US - June 24th, 2017 [June 24th, 2017]
- The Refugee Funding America's Psychedelic Renaissance - VICE - June 24th, 2017 [June 24th, 2017]
- Open Your Mind This Weekend at Europe's Largest Psychedelic Conference - VolteFace Magazine (blog) - June 27th, 2017 [June 27th, 2017]
- Psychedelics and Virtual Reality Make a Trendy but Illegal Therapy - Inverse - June 27th, 2017 [June 27th, 2017]
- The war on drugs is back. Will psychedelic drug research survive? - The Verge - June 29th, 2017 [June 29th, 2017]
- Tune in, Turn on, Stay in School - Study Breaks - July 2nd, 2017 [July 2nd, 2017]
- Cannabist Show: He's psychedelic comedian Shane Mauss - The Cannabist - July 2nd, 2017 [July 2nd, 2017]
- The brain on DMT: mapping the psychedelic drug's effects - Wired.co.uk - July 3rd, 2017 [July 3rd, 2017]
- Psychedelics Could Help Asia's Mental Health Care, But Stigma Remains Roadblock - TheFix.com - July 3rd, 2017 [July 3rd, 2017]
- Is LSD the new coffee? - FactorDaily - July 4th, 2017 [July 4th, 2017]
- My grandfather was a death row doctor. He tested psychedelic drugs on Texas inmates. - Texas Tribune - July 5th, 2017 [July 5th, 2017]
- About Us | Trusted News Source for Psychedelic Research ... - July 6th, 2017 [July 6th, 2017]
- Do Psychedelic Drugs Cause the 'Prophetic Effect'? - Breaking Israel News - July 11th, 2017 [July 11th, 2017]
- Are psychedelics the new medical marijuana? - WTSP 10 News - July 14th, 2017 [July 14th, 2017]
- Psychiatrists Say Cannabis Medicine Has Psychedelic Properties - The Marijuana Times - July 15th, 2017 [July 15th, 2017]
- Can Psychedelics Be Therapy? Allow Research to Find Out - New York Times - July 17th, 2017 [July 17th, 2017]
- Countdown To (Legalized) Ecstasy! Rick Doblin, MAPS, & the Psychedelic Renaissance [Podcast] - Reason (blog) - July 20th, 2017 [July 20th, 2017]
- Should We Reclassify Marijuana as a Hallucinogen? - Big Think - July 20th, 2017 [July 20th, 2017]
- Do You Take Drugs at Festivals? This Initiative is Working on Keeping You Safe - PoliticalCritique.org - July 20th, 2017 [July 20th, 2017]
- Psychedelic drugs could tackle depression in a way that antidepressants can't - INSIDER - July 22nd, 2017 [July 22nd, 2017]
- Psychedelic Shine takes a trip to the skies in Boulder - Boulder Daily Camera - July 22nd, 2017 [July 22nd, 2017]
- Reasons to Consider Trying Psychedelics - FoxWeekly - July 27th, 2017 [July 27th, 2017]
- Psychedelics and Normality - HuffPost - July 27th, 2017 [July 27th, 2017]
- New book about psychedelics and weird human experiences - Boing Boing - July 27th, 2017 [July 27th, 2017]
- Scientists Want You to Give Them Money to Study ... - July 29th, 2017 [July 29th, 2017]
- What Has Awe Done for Me Lately? - HuffPost - August 1st, 2017 [August 1st, 2017]
- For children, it's beyond psychedelics - The Hans India - The Hans India - August 1st, 2017 [August 1st, 2017]
- Expanding consciousness - 48 Hills - August 2nd, 2017 [August 2nd, 2017]
- THE FUTURE OF PSYCHEDELICS: Are LSD and Mushrooms The New Prozac? - Dope Magazine - August 5th, 2017 [August 5th, 2017]
- Psychedelic drugs saved my life. So why aren't they prescribed? - Wired.co.uk - August 9th, 2017 [August 9th, 2017]
- LSD as therapy: How scientists are reclaiming psychedelics ... - August 9th, 2017 [August 9th, 2017]
- The foundation of Western philosophy is probably rooted in psychedelics - Quartz - August 12th, 2017 [August 12th, 2017]
- Crazy Enough to be Correct - HuffPost - August 15th, 2017 [August 15th, 2017]